Details of the Drug

General Information of Drug (ID: DMET2A5)

Drug Name

PTR-01

Indication

Disease Entry	ICD 11	Status	REF
Dystrophic epidermolysis bullosa	EC32	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05143190) A Phase 2b Open-Label Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01 in Study PTR-01-002. U.S.National Institutes of Health.